Blog
44 Articles
![abstract DNA image in bright greens and reds](https://letswinpc.org/wp-content/uploads/2022/09/ct2021may25.jpg)
PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations
A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.
![DNA aqua pipette](https://letswinpc.org/wp-content/uploads/2022/10/DNA-aqua-pipette.jpg)
Exploiting DNA Mutations For Pancreatic Cancer Treatment
Dr. James Cleary explains how the researchers at Dana-Farber are looking to make PARP inhibitors even more effective for pancreatic cancer patients.
![Gloria Peterson, Ph.D.](https://letswinpc.org/wp-content/uploads/2022/10/GPetersen-Photo2-1.jpg)
Genetic Testing for All Pancreatic Cancer Patients
A study by Dr. Gloria Petersen’s research team has led to an official recommendation that all pancreatic cancer patients get genetic testing.
![Dr. Allyson Ocean](https://letswinpc.org/wp-content/uploads/2022/10/Allyson_Ocean.jpg)
Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019
Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.
![Dr. Sapna Syngal](https://letswinpc.org/wp-content/uploads/2022/10/Sapna.jpg)
New NCCN Guidelines Stress Genetic Testing For All Pancreatic Cancer Patients
Genetics impact your treatment for pancreatic cancer. Dr. Sapna Syngal discusses the recommendation of genetic testing for all pancreatic cancer patients.
![Kim Reiss Binder](https://letswinpc.org/wp-content/uploads/2022/10/Kim-Reiss-Binder.jpg)
PARP Inhibitors for Pancreatic Cancer Maintenance Treatment
Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.